{
  "folder": "IC-191",
  "content": "{{knowledge objective\n|Identifiant=OIC-191-11-B\n|Item_parent=Fever in an immunocompromised patient\n|Item_parent_short=Fever in an immunocompromised patient\n|Rank=B\n|Item_parent_short=Fever in immunocompromised patients\n|Description=None\n|Heading=Management\n|Contributors=Am\u00e9lie Servettaz,Jean-Daniel Leli\u00e8vre\n|Order=11}}\n\nVaccination in the case of immunodepression has certain specific features which justify specific recommendations\n\n* the risk of developing vaccine disease after administration of a live vaccine contraindicates the use of these vaccines in immunocompromised patients;\n* the reduced immunogenicity of vaccines may, in some cases, justify special vaccination regimens;\n* an increased risk of complications associated with certain infections justifies the recommendation of specific vaccinations.\n* When immunosuppressive treatment can be planned, patients should be vaccinated at least 2 weeks before the start of the treatment.\n* In certain situations, protective serum antibodies may be measured four to six weeks after vaccination (or at a later date) in order to check the immunogenicity of the vaccination and suggest additional injections if the response is insufficient.\n\n'''''Counter indications'''''\n\n*The existence of an immune deficiency is a contraindication to vaccination with a live attenuated vaccine (MMR, BCG, oral polio vaccine, yellow fever, VZV).\n\n'''''Indications'''''\n\n*In immunocompromised patients, we must ensure that the vaccination schedule is up to date.\n*Immunocompromised patients should receive an influenza vaccination every year.\n*Certain specific vaccines will be used depending on the immunodeficiency concerned.\n\n\nExamples:\n\n''Patients living with HIV:''\n\n* Schedule vaccines\n* Pneumococcal vaccination: conjugate vaccine then polysaccharide vaccine 2 months and 5 years later\n* Annual influenza vaccination\n* Vaccination against HBV\n* Live attenuated vaccines contraindicated if CD4<0.2G/L\n\n<br />",
  "question": {
    "question": "In immunocompromised patients, what is the recommended timing for vaccination before starting immunosuppressive treatment?",
    "option_a": "At the start of treatment",
    "option_b": "At least 2 weeks before the start of treatment",
    "option_c": "After the completion of treatment",
    "option_d": "Only if the patient has a specific immunodeficiency"
  }
}